Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 28, Number 12—December 2022

CME ACTIVITY - Research

Acinetobacter baumannii among Patients Receiving Glucocorticoid Aerosol Therapy during Invasive Mechanical Ventilation, China

Wenchao Zhang1, Mei Yin1, Wei Li, Nana Xu, Haining Lu, Weidong Qin, Hui Han, Chen Li, Dawei Wu, and Hao WangComments to Author 
Author affiliations: Qilu Hospital of Shandong University, Jinan, China (W. Zhang, M. Yin, W. Li, N. Xu, W. Qin, H. Han, C. Li, H. Wang); Qingdao Branch, Qilu Hospital of Shandong University, Qingdao, China (H. Lu, D. Wu)

Main Article

Figure 1

Flowchart for enrolling participants in a study of Acinetobacter baumannii among patients receiving glucocorticoid aerosol therapy during invasive mechanical ventilation, China. ICU, intensive care units.

Figure 1. Flowchart for enrolling participants in a study of Acinetobacter baumannii among patients receiving glucocorticoid aerosol therapy during invasive mechanical ventilation, China. ICU, intensive care units.

Main Article

1These authors contributed equally to this article.

Page created: October 17, 2022
Page updated: November 17, 2022
Page reviewed: November 17, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external